Want to see JP:3636 full AI Analyst Report?
3636 Stock Chart & Stats
¥4860.00
-¥5.00(-0.10%)
At close: 4:00 PM EST
¥4860.00
-¥5.00(-0.10%)
Day’s Range― - ―
52-Week Range¥4,375.00 - ¥5,360.00
Previous CloseN/A
Volume35.50K
Average Volume (3M)24.01K
Market Cap
¥76.71B
Enterprise Value¥38.21K
Total Cash (Recent Filing)¥41.91B
Total Debt (Recent Filing)¥982.00M
Price to Earnings (P/E)9.2
Beta0.70
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.38%
Share Statistics
EPS (TTM)525.61
Shares Outstanding16,044,000
10 Day Avg. Volume20,130
30 Day Avg. Volume24,010
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio29.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)420.2
Revenue Forecast (FY)¥126.61B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage (debt-to-equity 0.014) and a robust equity base give the company durable financial flexibility. This reduces refinancing and solvency risk, supports stable dividend and investment capacity, and allows strategic spending during downturns without stressing cash flow.
Margin Improvement & ProfitabilityConsistent revenue growth with rising gross margin and solid net margin indicates improved cost control and operational efficiency. Positive EBIT/EBITDA trends point to sustainable core profitability that can support reinvestment, client servicing and steady earnings over the medium term.
Healthy Operating Cash FlowStable operating cash flow relative to net income demonstrates reliable cash generation from core operations. This underpins the firm’s ability to fund working capital, service obligations, and maintain dividends without needing to rely on external financing, supporting long-term financial resilience.
Bears Say
Declining Free Cash Flow GrowthA notable drop in free cash flow growth weakens the company’s capacity to fund discretionary investments, acquisitions, or larger shareholder returns. Over several quarters this could constrain strategic initiatives, limit balance sheet optimization, and reduce buffer against unexpected spending needs.
Lower Return On EquityA declining ROE signals the company is generating lower returns from shareholders' equity, implying reduced capital efficiency. Persistently weaker ROE can make it harder to meet investor expectations, restrain equity-based growth strategies, and indicate margins or asset utilization need structural improvement.
Concentration In Consulting/Public-Sector WorkHeavy exposure to consulting and public-sector contracts makes revenue project-driven and sensitive to government budgets and procurement cycles. This business mix can produce lumpy revenues, long sales cycles and slower scalability versus product-led models, limiting sustained top-line acceleration.
Mitsubishi Research Institute News
3636 FAQ
What was Mitsubishi Research Institute’s price range in the past 12 months?
Mitsubishi Research Institute lowest stock price was ¥4375.00 and its highest was ¥5360.00 in the past 12 months.
What is Mitsubishi Research Institute’s market cap?
Mitsubishi Research Institute’s market cap is ¥76.71B.
When is Mitsubishi Research Institute’s upcoming earnings report date?
Mitsubishi Research Institute’s upcoming earnings report date is Nov 04, 2026 which is in 77 days.
How were Mitsubishi Research Institute’s earnings last quarter?
Mitsubishi Research Institute released its earnings results on Jul 29, 2026. The company reported -¥100.96 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Mitsubishi Research Institute overvalued?
According to Wall Street analysts Mitsubishi Research Institute’s price is currently Overvalued.
Does Mitsubishi Research Institute pay dividends?
Mitsubishi Research Institute pays a Semiannually dividend of ¥85 which represents an annual dividend yield of 3.38%. See more information on Mitsubishi Research Institute dividends here
What is Mitsubishi Research Institute’s EPS estimate?
Mitsubishi Research Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mitsubishi Research Institute have?
Mitsubishi Research Institute has 16,044,000 shares outstanding.
What happened to Mitsubishi Research Institute’s price movement after its last earnings report?
Mitsubishi Research Institute reported an EPS of -¥100.96 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.758%.
Which hedge fund is a major shareholder of Mitsubishi Research Institute?
Currently, no hedge funds are holding shares in JP:3636
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mitsubishi Research Institute
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financial organizations, and private corporations. The company's extensive solutions span areas such as management consultation, digital and financial innovation, environmental and energy initiatives, healthcare and wellness, regional development, future infrastructure deployment, scientific and safety research, nuclear safety, and broad economic, social, and R&D initiatives. Furthermore, MRI handles specialized project engagements and public sector procurement. In a key collaboration, it partners with ForePaaS SAS to implement cloud-native data-intensive solutions across Japan. Established in 1970, Mitsubishi Research Institute, Inc. is headquartered in Tokyo.